Momenta Pharma
(MNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Sales | 87,945 | 87,496 | 78,172 | 58,326 | 51,961 |
| Gross Profit | 87,945 | 87,496 | 78,172 | 58,326 | 51,961 |
| Operating Expenses | 27,787 | 23,373 | 21,253 | 23,027 | 19,813 |
| Operating Income | 60,158 | 64,123 | 56,919 | 35,299 | 32,148 |
| Interest Expense | 14 | 34 | 41 | 63 | 74 |
| Other Income | 194 | 176 | 128 | 1,022 | 46 |
| Pre-tax Income | 60,338 | 64,265 | 57,006 | 36,258 | 32,120 |
| Net Income Continuous | 60,338 | 64,265 | 57,006 | 36,258 | 32,120 |
| Net Income | $60,338 | $64,265 | $57,006 | $36,258 | $32,120 |
| EPS Basic Total Ops | 1.21 | 1.29 | 1.15 | 0.83 | 0.72 |
| EPS Basic Continuous Ops | 1.21 | 1.29 | 1.15 | 0.83 | 0.72 |
| EPS Diluted Total Ops | 1.18 | 1.26 | 1.13 | 0.82 | 0.70 |
| EPS Diluted Continuous Ops | 1.18 | 1.26 | 1.13 | 0.82 | 0.70 |
| EBITDA(a) | $62,612 | $65,695 | $58,356 | $36,684 | $33,385 |